Codexis Inc (CDXS)
2.80
-0.10
(-3.45%)
USD |
NASDAQ |
Apr 24, 16:00
2.81
+0.01
(+0.36%)
After-Hours: 20:00
Codexis Cash from Investing (TTM): -4.858M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -4.858M |
September 30, 2023 | -5.929M |
June 30, 2023 | -6.131M |
March 31, 2023 | -6.78M |
December 31, 2022 | -13.58M |
September 30, 2022 | -19.09M |
June 30, 2022 | -28.78M |
March 31, 2022 | -28.97M |
December 31, 2021 | -21.42M |
September 30, 2021 | -18.43M |
June 30, 2021 | -8.203M |
March 31, 2021 | -7.52M |
December 31, 2020 | -5.748M |
September 30, 2020 | -3.674M |
June 30, 2020 | -4.898M |
March 31, 2020 | -3.981M |
December 31, 2019 | -3.665M |
September 30, 2019 | -3.944M |
June 30, 2019 | -2.551M |
March 31, 2019 | -3.195M |
December 31, 2018 | -2.766M |
September 30, 2018 | -2.318M |
June 30, 2018 | -1.778M |
March 31, 2018 | -0.763M |
December 31, 2017 | -0.983M |
Date | Value |
---|---|
September 30, 2017 | -0.836M |
June 30, 2017 | -1.076M |
March 31, 2017 | -0.844M |
December 31, 2016 | -0.846M |
September 30, 2016 | -1.647M |
June 30, 2016 | -1.451M |
March 31, 2016 | -1.448M |
December 31, 2015 | -1.257M |
September 30, 2015 | -0.391M |
June 30, 2015 | -0.186M |
March 31, 2015 | 0.994M |
December 31, 2014 | 4.647M |
September 30, 2014 | 4.239M |
June 30, 2014 | 7.184M |
March 31, 2014 | 14.43M |
December 31, 2013 | 13.27M |
September 30, 2013 | 24.52M |
June 30, 2013 | 33.61M |
March 31, 2013 | 19.17M |
December 31, 2012 | 16.71M |
September 30, 2012 | 4.349M |
June 30, 2012 | -12.65M |
March 31, 2012 | -20.78M |
December 31, 2011 | -48.81M |
September 30, 2011 | -70.99M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-28.97M
Minimum
Mar 2022
-2.551M
Maximum
Jun 2019
-10.43M
Average
-6.131M
Median
Jun 2023
Cash from Investing (TTM) Benchmarks
Sutro Biopharma Inc | -3.924M |
Avidity Biosciences Inc | -130.07M |
Taysha Gene Therapies Inc | -7.352M |
Janux Therapeutics Inc | -41.19M |
Tango Therapeutics Inc | 41.43M |